美股异动 | 诺瓦瓦克斯医药(NVAX.US)涨近10% BTIG首予其“买入”评级

智通财经
28 Feb

智通财经APP获悉,周五,诺瓦瓦克斯医药(NVAX.US)股价走高,截至发稿,该股涨近10%,报7.765美元。BTIG分析师Thomas Shrader首予诺瓦瓦克斯医药“买入”评级,目标价19美元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10